ClinicalTrials.gg
RecruitingNCT06370312Updated Jun 25, 2025

Analysis of Articular Biomarkers From Osteoarthritic Thumb Basal Joints

An observational study in Osteoarthritis Thumb, Osteoarthritis, Knee and Metabolic Disease, sponsored by Region Skane. Recruiting at 2 sites in Sweden. Open to participants aged 25 Years and older. Per ClinicalTrials.gov, last updated 2025-06-25.

Sponsored by Region Skane · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Apr 2026, 6 months ago, but the record still lists the study as recruiting.
  • Started May 2024; still recruiting 2 years 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
120
Ages
25 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 54 studies in Osteoarthritis, Knee with a site in Sweden — 12 open to participants now, 19 under way, none of them phase 3. Osteoarthritis, Knee · Sweden.

Planned enrollment
11th of 16
120 · median 246
Started
2024
with 4 others
Observational
16 of 54
5 open now
Primary completion
2026-04
later than 7 of 18 live
Registered
44th of 54
by date
Lead sponsor
6 of 54
Region Skane

Among the 54 studies in Osteoarthritis, Knee with a site in Sweden, this one is the 11th largest by planned enrollment of the 16 observational ones that give a count, is one of 5 that started in 2024, is one of 16 observational ones, reaches primary completion later than 7 of the 18 other live ones, and was the 44th registered.

Osteoarthritis, Knee

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

Browse Osteoarthritis, Knee studies →

Open to participants now

12 of the 54 studies in Osteoarthritis, Knee with a site in Sweden are open now. Recruiting first, the newest first:

6 more — sign in →

All 12 open studies →

A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →

Who these studies take

Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.

This study: 25 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 54 studies in Osteoarthritis, Knee with a site in Sweden, or all of them as a file.
02

Study summary

The study project aims at examining molecular markers in synovial fluid, bone and articular cartilage from osteoarthritic thumb basal joints. The degradation of extracellular matrix (ECM) proteins in thumb basal joints will be evaluated in association to the metabolic profile of the patient, but we also aim to compare the ECM degradation and inflammatory profiles with articular cartilage degradation ECM profile from knee joints with osteoarthritis. A third aim is to evaluate associations between patient-reported hand function, pain, strength and range of thumb motion to analyses of synovial fluid.

Read the detailed description

Patients scheduled for trapeziectomy on the basis of thumb basal joint osteoarthritis will be asked to participate. Synovial fluid from the thumb basal joint is aspirated before the joint is opened. The trapezium bone and cartilage is harvested. Blood samples to evaluated lipid profile and glucose intolerance is drawn. Blood pressure and measurements of obesity is taken. Patients are also examined at baseline and 1 year postop with grip strength, pinch strength, range of thumb motion and asked to fill in patient-rated outcome measures; QuickDASH and NRS pain.

03

Conditions studied

  • Osteoarthritis Thumb
  • Osteoarthritis, Knee
  • Metabolic Disease
04

Who can participate

Ages eligible
25 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

All patients fulfilling the eligibility criteria and are scheduled for surgery at any of two study centres; Department of hand surgery, Skane university hospital or Aleris Malmö Arena (private clinic), due to symptomatic thumb basal joint OA are invited to participate. Indications for surgery at these to clinics are; 1) persistent pain and pain at rest, 2) have tried conservative treatment with inadequate effect.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Men and women age ≥ 25 years
  • Radiologically confirmed and symptomatic thumb basal joint osteoarthritis (OA) planned for trapeziectomy

Exclusion criteria

Exclusion Criteria:

  • Previous surgery to the affected thumb basal joint
  • Post-traumatic thumb basal joint OA
  • Rheumatoid arthritis or other chronic inflammatory arthritis, history of psoriasis affecting joints, gout or pseudogout
  • Ongoing infection in the hand or wrist
  • Inability to co-operate with the follow-up protocol or to assimilate information about the study protocol (language difficulties, severe psychiatric disorder, cognitive impairment, drug addiction)
  • Systemic or intra-articular or intraarticular -rich plasma or hyaluronic acid injections in the affected joint within 3 months prior to enrollment
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

Platelets

Blood cells that help blood clot. Too few raises the risk of bleeding and bruising. A usual adult range is about 150–400 × 10⁹/L (150,000–400,000 per µL); each lab has its own reference range.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
120 participants (estimated)
Patient registry
No
Biospecimen retention
Samples without dna

Interventions

  • ProcedureTrapeziectomy

    Patients scheduled for trapeziectomy due to thumb basal joint osteoarthritis are invited to participate. Synovial fluid is aspirated before the joint is opened. Bone and cartilage are collected. Blood samples are obtained preop. Patients are measured with grip strength, pinch strength, range of thumb motion, body mass index, central obesity and blood pressure.

06

What researchers measure

Primary outcomes

  1. Serum cholesterol levels

    Blood samples are drawn from the patients and analysed according to Swedish laboratory standards

    Time frame: Serum cholesterol levels are drawn at baseline (i.e. the day of surgery)

07

Study locations

1 of 2 sites recruiting
  • Department of Hand Surgery, Skane University Hospital
    Malmo, Skåne County 20502, Sweden
    Not yet recruiting
  • Aleris Specialistläkare Hyllie
    Malmo, Skåne County 21532, Sweden
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — No sharing

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2024 (actual). Primary completion is estimated for Apr 2026, 23 months after the start.

Of 179 non-industry observational studies under Osteoarthritis, Knee, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 48. This study's planned 23 months is close to that.

Counting every sponsor, half of 220 studies reached it within 24 months; a quarter within 13 and three quarters within 61.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 4, 2024
First posted
Apr 17, 2024
StartActual
May 1, 2024
Primary completionEst.
Apr 30, 2026
CompletionEst.
Apr 30, 2027
Last update
Jun 25, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 25, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06370312
Lead sponsor
Region Skane
Responsible party
Sponsor
First posted
Apr 17, 2024
Start date
May 1, 2024
Primary completion
Apr 30, 2026 (estimated)
Completion
Apr 30, 2027 (estimated)
Last update
Jun 25, 2025

Study contacts

Elisabeth Brogren, MD, PhD
Contact
elisabeth.brogren@med.lu.se
+46 40331723
My von Walter, MD
Contact
Elisabeth Brogren, MD, PhD
principal investigator · Department of hand surgery, Region Skåne

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion